The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
A Seven-transmembrane, G Protein–coupled Receptor, FPRL1, Mediates the Chemotactic Activity of Serum Amyloid A for Human Phagocytic Cells
Open accessAbstract
We have previously reported (Badolato, R., J.M. Wang, W.J. Murphy, A.R. Lloyd, D.F. Michiel, L.L. Bausserman, D.J. Kelvin, and J.J. Oppenheim. 1994. J. Exp. Med. 180:203; Xu, L., R. Badolato, W.J. Murphy, D.L. Longo, M. Anver, S. Hale, J.J. Oppenheim, and J.M. Wang. 1995. J. Immunol. 155:1184.) that the acute phase protein serum amyloid A (SAA) is a potent chemoattractant for human leukocytes in vitro and mouse phagocytes in vivo. To identify the signaling mechanisms, we evaluated patterns of cross-desensitization between SAA and other leukocyte chemoattrctants. We found that the chemotactic bacterial peptide, N-formyl- methionyl-leucyl-phenylalanine (fMLP), was able to specifically attenuate Ca2+ mobilization in human phagocytes induced by SAA, but only at very high concentrations, suggesting that SAA uses a low affinity fMLP receptor. Here we demonstrate that SAA selectively induced Ca2+ mobilization and migration of HEK cells expressing FPRL1, a human seven-transmembrane domain phagocyte receptor with low affinity for fMLP, and high affinity for lipoxin A4. Furthermore, radiolabeled SAA specifically bound to human phagocytes and FPRL1-transfected 293 cells. In contrast, SAA was not a ligand or agonist for FPR, the high affinity fMLP receptor. Thus, SAA is the first chemotactic ligand identified for FPRL1. Our results suggest that FPRL1 mediates phagocyte migration in response to SAA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration
Falk, W., Goodwin, R. H., & Leonard, E. J. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90211-2 · Cited by 941
Badolato, R., Wang, J. M., Murphy, W. J., Lloyd, A. R., Michiel, D. F., Bausserman, L. L., Kelvin, D. J., & Oppenheim, J. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.203 · Cited by 500
Self-citationIdentification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.
Fiore, S., Maddox, J. F., Perez, H. D., & Serhan, C. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.253 · Cited by 436
Takano, T., Fiore, S., Maddox, J. F., Brady, H. R., Petasis, N. A., & Serhan, C. N. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1693 · Cited by 431
Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice
MALLE, E., & DE BEER, F. C. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.159291.x · Cited by 346
HIV entry and tropism: the chemokine receptor connection.
Berger, E. A. (1997) · PubMed · Cited by 313
Maddox, J. F., Hachicha, M., Takano, T., Petasis, N. A., Fokin, V. V., & Serhan, C. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6972 · Cited by 266
Cited by
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672
Yang, D., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., & Chertov, O. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1069 · Cited by 1,240
Self-citationSerum amyloid A, the major vertebrate acute‐phase reactant
Uhlar, C. M., & Whitehead, A. S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00657.x · Cited by 1,106
Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001578 · Cited by 764
Self-citationFormyl-peptide receptors revisited
LE, Y., MURPHY, P., & WANG, J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02316-5 · Cited by 597
Self-citationAn Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm
Bottazzi, B., Doni, A., Garlanda, C., & Mantovani, A. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101305 · Cited by 592
Acute phase proteins in ruminants
Ceciliani, F., Ceron, J. J., Eckersall, P. D., & Sauerwein, H. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.04.004 · Cited by 572
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
A Second Leukotriene B4 Receptor, Blt2
Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.421 · Cited by 538
Sack, G. H. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0047-0 · Cited by 499
Urieli-Shoval, S., Linke, R. P., & Matzner, Y. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200001000-00012 · Cited by 465
MIGEOTTE, I., COMMUNI, D., & PARMENTIER, M. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.009 · Cited by 457
Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression
Jernås, M., Palming, J., Sjöholm, K., Jennische, E., Svensson, P.-A., Gabrielsson, B. G., Levin, M., Sjögren, A., Rudemo, M., Lystig, T. C., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5678fje · Cited by 454
Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm786 · Cited by 447
New Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391
Self-citationSerum amyloid A induces IL-8 secretion through a G protein–coupled receptor, FPRL1/LXA4R
He, R., Sang, H., & Ye, R. D. (2003) · Blood · doi:10.1182/blood-2002-05-1431 · Cited by 329
A Novel Ligand of the Formyl Peptide Receptor
Walther, A., Riehemann, K., & Gerke, V. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80323-8 · Cited by 317
Emerging functions of serum amyloid A in inflammation
Ye, R. D., & Sun, L. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3vmr0315-080r · Cited by 311
Dufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H. B., Gray, M., D’Acquisto, F., Buckingham, J. C., Perretti, M., & Flower, R. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903526 · Cited by 302
Niemi, K., Teirilä, L., Lappalainen, J., Rajamäki, K., Baumann, M. H., Öörni, K., Wolff, H., Kovanen, P. T., Matikainen, S., & Eklund, K. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002843 · Cited by 298
Nagata, K., Hirai, H., Tanaka, K., Ogawa, K., Aso, T., Sugamura, K., Nakamura, M., & Takano, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01251-x · Cited by 297
Mitchell, S., Thomas, G., Harvey, K., Cottell, D., Reville, K., Berlasconi, G., Petasis, N. A., Erwig, L., Rees, A. J., Savill, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032417.73640.72 · Cited by 287
“In addition to binding LXA4 and its analogues, the ALXR has recently been shown to bind specific peptides (19,27), the acute phase protein serum amyloid A (SAA) (48), prion protein (49), and amyloid (50).”
BackgroundCutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
Cheng, N., He, R., Tian, J., Ye, P. P., & Ye, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.22 · Cited by 284
Human Formyl Peptide Receptor 2 Senses Highly Pathogenic Staphylococcus aureus
Kretschmer, D., Gleske, A.-K., Rautenberg, M., Wang, R., Köberle, M., Bohn, E., Schöneberg, T., Rabiet, M.-J., Boulay, F., Klebanoff, S. J., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.05.012 · Cited by 282
Yang, D., Chertov, O., & Oppenheim, J. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.5.691 · Cited by 279
Self-citationThe Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
He, H.-Q., & Ye, R. (2017) · Molecules · doi:10.3390/molecules22030455 · Cited by 279
Amyloid β42Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1
Le, Y., Gong, W., Tiffany, H. L., Tumanov, A., Nedospasov, S., Shen, W., Dunlop, N. M., Gao, J.-L., Murphy, P. M., Oppenheim, J. J., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0003.2001 · Cited by 270
Self-citationChiang, N., Fierro, I. M., Gronert, K., & Serhan, C. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1197 · Cited by 260
Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX
Chiang, N., Arita, M., & Serhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.003 · Cited by 239
Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2
Li, Y., Cai, L., Wang, H., Wu, P., Gu, W., Chen, Y., Hao, H., Tang, K., Yi, P., Liu, M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.112 · Cited by 192
“On the other hand, by binding other ligands such as SAA and cathelicidin LL-37, FPR2 also assumes a proinflammatory role such as chemoattraction and activation of human neutrophils, monocytes and T cells, and amplification of innate and adaptive immune responses, thereby modulating chemoattraction, dendritic cell diff…”
BackgroundBozinovski, S., Uddin, M., Vlahos, R., Thompson, M., McQualter, J. L., Merritt, A.-S., Wark, P. A. B., Hutchinson, A., Irving, L. B., Levy, B. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109382109 · Cited by 163
Homologues of Human Macrophage Migration Inhibitory Factor from a Parasitic Nematode
Zang, X., Taylor, P., Wang, J. M., Meyer, D. J., Scott, A. L., Walkinshaw, M. D., & Maizels, R. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204655200 · Cited by 108
Self-citationSerum Amyloid A Is an Endogenous Ligand That Differentially Induces IL-12 and IL-23
He, R., Shepard, L. W., Chen, J., Pan, Z. K., & Ye, R. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4072 · Cited by 100
Serum amyloid A induces interleukin‐33 expression through an IRF7‐dependent pathway
Sun, L., Zhu, Z., Cheng, N., Yan, Q., & Ye, R. D. (2014) · European Journal of Immunology · doi:10.1002/eji.201344310 · Cited by 41
Li, M., Kim, Y.-M., Koh, J. H., Park, J., Kwon, H. M., Park, J.-H., Jin, J., Park, Y., Kim, D., & Kim, W.-U. (2024) · Journal of Clinical Investigation · doi:10.1172/jci167835 · Cited by 25
Metadata
- Authors
- Su, S. B., Gong, W., Gao, J.-L., Shen, W., Murphy, P. M., Oppenheim, J. J., & Wang, J. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-01-18
- Volume
- 189
- Issue
- 2
- Pages
- 395-402
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2132342511
- Cited by
- 429
- References
- 39
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.